Overview

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases.
Phase:
Phase 3
Details
Lead Sponsor:
Eisai Inc.
Treatments:
Zonisamide